DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro

被引:5
|
作者
Shahab, Siyamak [1 ,2 ,3 ]
Kaviani, Sadegh [4 ]
Sheikhi, Masoome [5 ]
Almodarresiyeh, Hora Alhosseini [6 ]
Al Saud, Sultan [1 ,3 ]
机构
[1] Belarusian State Univ, ISEI BSU, Minsk, BELARUS
[2] Natl Acad Sci Belarus, Inst Phys Organ Chem, 13 Surganov Str, Minsk 220072, BELARUS
[3] Natl Acad Sci Belarus, Inst Chem New Mat, 36 Skarina Str, Minsk 220141, BELARUS
[4] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Razavi Khorasan, Iran
[5] Islamic Azad Univ, Gorgan Branch, Young Researchers & Elite Club, Gorgan, Golestan, Iran
[6] Meybod Univ, Sch Engn, Dept Mat Sci & Engn, Meybod 8961699557, Yazd, Iran
来源
关键词
SARS-CoV-2 main protease M-pro; DFT; molecular docking; chlorogenic; Ellagic and Quisqualic acids; pharmacokinetic properties; COFFEE; METABOLITES; DERIVATIVES; DISCOVERY; TRANSPORT; UV/VIS; HUMANS;
D O I
10.33263/BRIAC121.061073
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In the present work, at first, density functional theory calculations were performed to investigate the molecular structure of the Chlorogenic, Ellagic, and Quisqualic acids by CAM-B3LYP/MidiX level of theory. A detail of quantum molecular descriptors of the title compounds such as ionization potential (IP) and Electron Affinities (EA), Hardness (eta), Softness (S), Electronegativity (mu), Electrophilic Index (omega), Electron Donating Power (omega-), Electron Accepting Power (omega+) and Energy Gap (Eg) have been calculated. Pharmacokinetic properties of the title compounds and their bioactivity were investigated. In the following, a molecular docking study was carried out to screen for an effective available compound that may work as a strong inhibitor for the SARS-CoV-2 main protease Mpro. The binding energy between SARS-CoV-2 main protease Mpro and title organic acids showed a good binding affinity. Therefore, the Chlorogenic, Ellagic, and Quisqualic acids can be used for potential application against the SARS-CoV-2 main protease Mpro.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [1] In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro)
    Victoria Adeola Falade
    Temitope Isaac Adelusi
    Ibrahim Olaide Adedotun
    Misbaudeen Abdul-Hammed
    Teslim Alabi Lawal
    Saheed Alabi Agboluaje
    [J]. In Silico Pharmacology, 9 (1)
  • [2] Repurposing Anthocyanins into Potential Inhibitors of the SARS-CoV-2 Main Protease (Mpro): an In Silico Approach
    Oyong, Glenn
    Cuevas, Joshua Godwin
    Gonzales, Bryant Kimm
    Nuniala, Louiejabe
    Singson, Rene Louis
    [J]. INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, ICOBE 2021, 2023, 2562
  • [3] In silico approach identified benzoylguanidines as SARS-CoV-2 main protease (Mpro) potential inhibitors
    de Santiago-Silva, Kaio Maciel
    Camargo, Priscila
    da Silva Gomes, Gabriel Felix
    Sotero, Ana Paula
    Orsato, Alexandre
    Perez, Carla Cristina
    Nakazato, Gerson
    da Silva Lima, Camilo Henrique
    Bispo, Marcelle
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (16): : 7686 - 7699
  • [4] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
    Soumya Gulab Katre
    Alpana Jagdish Asnani
    Kumar Pratyush
    Nilima Gangadhar Sakharkar
    Ashwini Gajanan Bhope
    Kanchan Tekram Sawarkar
    Vaibhav Santosh Nimbekar
    [J]. Future Journal of Pharmaceutical Sciences, 8
  • [5] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
    Katre, Soumya Gulab
    Asnani, Alpana Jagdish
    Pratyush, Kumar
    Sakharkar, Nilima Gangadhar
    Bhope, Ashwini Gajanan
    Sawarkar, Kanchan Tekram
    Nimbekar, Vaibhav Santosh
    [J]. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 8 (01)
  • [6] Amentoflavone derivatives against SARS-CoV-2 main protease (MPRO): An in silico study
    Hossain, Rajib
    Mahmud, Shafi
    Khalipha, Abul Bashar Ripon
    Saikat, Abu Saim Mohammad
    Dey, Dipta
    Khan, Rasel Ahmed
    Rauf, Abdur
    Wadood, Abdul
    Rafique, Humaria
    Bawazeer, Sami
    Khalil, Anees Ahmed
    Almarhoon, Zainab M.
    Mabkhot, Yahia N.
    Alzahrani, Khalid J.
    Islam, Muhammad Torequl
    Alsharif, Khalaf F.
    Khan, Haroon
    [J]. MAIN GROUP CHEMISTRY, 2023, 22 (02) : 313 - 327
  • [7] Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors:in silicoanalysis
    Al-Sehemi, Abdullah G.
    Pannipara, Mehboobali
    Parulekar, Rishikesh S.
    Patil, Omkar
    Choudhari, Prafulla B.
    Bhatia, M. S.
    Zubaidha, P. K.
    Tamboli, Yasinalli
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (15): : 5804 - 5818
  • [8] Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
    Sayed, Ahmed M.
    Alhadrami, Hani A.
    El-Gendy, Ahmed O.
    Shamikh, Yara, I
    Belbahri, Lassaad
    Hassan, Hossam M.
    Abdelmohsen, Usama Ramadan
    Rateb, Mostafa E.
    [J]. MICROORGANISMS, 2020, 8 (07) : 1 - 17
  • [9] Primer for Designing Main Protease (Mpro) Inhibitors of SARS-CoV-2
    Thakur, Abhishek
    Sharma, Gaurav
    Badavath, Vishnu Nayak
    Jayaprakash, Venkatesan
    Merz, Kenneth M., Jr.
    Blum, Galia
    Acevedo, Orlando
    [J]. JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2022, 13 (25): : 5776 - 5786
  • [10] In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease
    Abdelrady, Yousef A.
    Ashraf, Naeem Mahmood
    Hamid, Arslan
    Thabet, Hayam S.
    Sayed, Asmaa M.
    Salem, Shimaa H.
    Hassanein, Emad H. M.
    Sayed, Ahmed M.
    [J]. FUTURE VIROLOGY, 2023, 18 (05) : 295 - 308